Administration of imatinib after allogeneic hematopoietic stem cell transplantation may improve disease-free survival for patients with Philadelphia chromosome-positive acute lymphobla stic leukemia

BACKGROUND: Maintenance therapy with imatinib during the post-transplant period has been used for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL); however, its efficacy has not been demonstrated. A study was designed to investigate the safety of imatinib and it...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Huan, Liu, Kai-yan, Xu, Lan-ping, Liu, Dai-hong, Chen, Yu-hong, Zhao, Xiang-yu, Han, Wei, Zhang, Xiao-hui, Wang, Yu, Zhang, Yuan-yuan, Qin, Ya-zhen, Liu, Yan-rong, Huang, Xiao-jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3407007/
https://www.ncbi.nlm.nih.gov/pubmed/22682059
http://dx.doi.org/10.1186/1756-8722-5-29

Ejemplares similares

Ejemplares similares